Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal Ablation
Recruiting
N/AInterventional Study
Cervical Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
21 – 60
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
565 (estimated)
Sponsor
University of Washington · Other
Who this trial is looking for
This trial is looking for women aged 25-60 who want to get screened for cervical cancer and have tested positive for pre-cancer lesions. Participants will receive a safe and effective treatment using a new method called thermal ablation.
Are You a Good Fit for This Trial?
You may be able to join if
I am a woman aged 25-60.
I am seeking cervical cancer screening services.
I have screened positive for pre-cancer lesions.
I can provide consent to participate.
I am a healthcare provider at a participating clinic.
I am a health facility manager.
I am a policymaker.
You may not be able to join if
I decline to participate in this trial.
I do not want my data collected for research.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Global elimination of cervical cancer is a feasible goal; however, the countries with the greatest disease burden also have the greatest healthcare system challenges. Cervical cancer (CC) is almost entirely preventable, yet, it remains the 2nd most common cause of cancer and is the most common cause of cancer deaths among women in the majority of Low-Middle-Income-Countries (LMIC) including Kenya.…
Global elimination of cervical cancer is a feasible goal; however, the countries with the greatest disease burden also have the greatest healthcare system challenges. Cervical cancer (CC) is almost entirely preventable, yet, it remains the 2nd most common cause of cancer and is the most common cause of cancer deaths among women in the majority of Low-Middle-Income-Countries (LMIC) including Kenya. Effective low-cost interventions for early detection of pre-cancer lesions have been available but there remains very low coverage with about 16% eligible women screened in Kenya. Cryotherapy has been introduced as a low-cost intervention for treatment of pre-cancer lesions, however, challenges with equipment shortage, costs, supply chain difficulties of refrigerant gas and equipment failure health facilities has been cited as a reason for the low treatment rates of screen positive women. In Kenya only about 30% of women screening positive access treatment for the pre-cancer lesions. This project will introduce thermal ablation (TA), which is proven to be safe and as effective as cryotherapy for treatment of pre-cancer lesions of the cervix. TA uses electricity, batteries or solar to charge, takes a shorter time to use, is a small easily portable equipment.
The primary aim of the study is to deliver, evaluate and cost implementation of the 'Single Visit Screen and Treat with Thermal Ablation' (SVA-SAT+TA) intervention for treatment of women who screen positive for pre-cancer lesions of the cervix in reproductive health clinics in Kenya, using implementation science framework to inform National scale-up.
To achieve national and global goals to eliminate cervical cancer, there is an urgent need to adapt, implement, and scale-up effective technologies in Kenya. The proposed research project will develop a contextually appropriate implementation and dissemination model to guide effective scale-up of the single visit screen and treat approach with use of thermal ablation to health facilities to bridge access to cervical cancer prevention services for women in Kenya and similar low resource settings.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Policy makers
* Health facility managers
* Health care providers at participating reproductive health clinics
* Women seeking cervical cancer screening services
* Women who screen positive for pre-cancer lesion of the cervix
* Consent to study participation
* Age 25-60 years
*…
Inclusion Criteria:
* Policy makers
* Health facility managers
* Health care providers at participating reproductive health clinics
* Women seeking cervical cancer screening services
* Women who screen positive for pre-cancer lesion of the cervix
* Consent to study participation
* Age 25-60 years
* Women seeking cervical cancer screening services at participating RH clinics
* Health care providers providing cervical cancer prevention services at participating RH clinics
Exclusion Criteria:
-Any individual who declines to participate or have their data collected for purpose of research
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.